Pre-made Mipasetamab Uzoptirine benchmark antibody (Whole mAb ADC, anti-AXL therapeutic antibody, Anti-ARK/JTK11/Tyro7/UFO Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-910
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
SKU GMP-Bios-INN-910 Category Tag

Product Details

Pre-made Mipasetamab Uzoptirine benchmark antibody (Whole mAb ADC, anti-AXL therapeutic antibody, Anti-ARK/JTK11/Tyro7/UFO Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Mipasetamab Uzoptirine Biosimilar, Whole Mab Adc, Anti-Axl Antibody: Anti-ARK/JTK11/Tyro7/UFO therapeutic antibody Drug Conjugate

INN Name

mipasetamab uzoptirine

Target

AXL

Format

Whole mAb ADC

Derivation

Humanized

Species Reactivity

Human

CH1 Isotype

IgG1 – kappa

VD LC

IgG1 – kappa

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

ADC?Therapeutics (Epalinges Switzerland)

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

GlycoConnect? ADC?(Synaffix)

Previous Name

NA

Gm Offical Target Name

AXL

Package

, ,

Genemeidi Omicron Variant Products
test
Previous
Next
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.